2022-08-09 Sale | 2022-08-11 4:55 pm | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 550,000 | $13.03 | $7,166,610 | 12,530,909 (Indirect Direct) | View |
2022-06-03 Sale | 2022-06-07 4:36 pm | Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner | 750,000 | $12.25 | $9,188,775 | 1,233,615 (Indirect Direct) | View |
2021-10-18 Sale | 2021-10-20 4:38 pm | Oyster Point Pharma Inc. | OYST | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC Versant Ventures IV LLC Versant Venture Capital IV L.P. Versant Side Fund IV L.P. 10% Owner | 550,000 | $14.84 | $8,160,736 | 3,245,533 (Indirect Direct) | View |
2021-06-29 Purchase | 2021-07-01 7:01 pm | Graphite Bio Inc. | GRPH | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 180,000 | $17 | $3,060,000 | 16,416,117 (Indirect Direct) | View |
2021-06-28 Purchase | 2021-06-30 5:00 pm | Monte Rosa Therapeutics Inc. | GLUE | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 157,895 | $19 | $3,000,005 | 8,897,053 (Indirect Direct) | View |
2021-06-22 Purchase | 2021-06-23 4:30 pm | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 100,000 | $20 | $2,000,000 | 13,630,909 (Indirect Direct) | View |
2020-11-30 Sale | 2020-12-01 7:13 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 10,393 | $33.15 | $344,513 | 6,062,813 (Indirect Direct) | View |
2020-11-19 Sale | 2020-11-23 4:41 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 130,017 | $33.01 | $4,291,861 | 7,646,829 (Indirect Direct) | View |
2020-11-17 Sale | 2020-11-19 9:19 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,730 | $33.05 | $156,349 | 7,776,846 (Indirect Direct) | View |
2020-11-13 Sale | 2020-11-17 7:33 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 4,700 | $33.74 | $158,587 | 7,781,576 (Indirect Direct) | View |
2020-11-12 Sale | 2020-11-13 7:47 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 15,598 | $34.15 | $532,642 | 6,937,033 (Indirect Direct) | View |
2020-11-10 Sale | 2020-11-12 5:41 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 39,583 | $34.11 | $1,350,354 | 8,751,874 (Indirect Direct) | View |
2020-11-06 Sale | 2020-11-10 7:24 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 9,400 | $33.08 | $310,949 | 8,791,457 (Indirect Direct) | View |
2020-11-04 Sale | 2020-11-06 4:44 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 11,348 | $33.14 | $376,127 | 8,800,857 (Indirect Direct) | View |
2020-10-26 Sale | 2020-10-28 5:58 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 8,903 | $33.28 | $296,293 | 8,812,205 (Indirect Direct) | View |
2020-10-15 Sale | 2020-10-20 8:09 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 15,746 | $33.44 | $526,529 | 8,821,108 (Indirect Direct) | View |
2020-10-20 Purchase | 2020-10-20 4:58 pm | Aligos Therapeutics Inc. | ALGS | Versant Venture Capital VI L.P. Versant Vantage I L.P. 10% Owner | 200,000 | $15 | $3,000,000 | 3,292,339 (Indirect Direct) | View |
2020-10-13 Sale | 2020-10-15 7:22 pm | Black Diamond Therapeutics Inc. | BDTX | Versant Venture Capital VI L.P. Versant Voyageurs I Parallel L.P. Versant Voyageurs I L.P. Versant Vantage I L.P. 10% Owner | 17,240 | $33.3 | $574,015 | 8,836,854 (Indirect Direct) | View |